Novel measures of cognition and function for the AD spectrum in the Novel Measures for Alzheimer's Disease Prevention Trials (NoMAD) project: Psychometric properties, convergent validation, and contrasts with established measures

Kim, H., Lee, S., Levine, A., Huber, B., Andrews, H., Kerner, N. A., Cohen, D., Carlson, S., Bell, S. A., Rivera, A. M., Gordon, M. L., Simoes, S., Devanand, Davangere. P., Brickman, A. M., Schneider, L. S., Harvey, P. D., & Goldberg, T. E. (2024). Novel measures of cognition and function for the AD spectrum in the Novel Measures for Alzheimer’s Disease Prevention Trials (NoMAD) project: Psychometric properties, convergent validation, and contrasts with established measures. Alzheimer’s & Dementia. Portico. https://doi.org/10.1002/alz.13757
Authors:
Hyun Kim
Seonjoo Lee
Alina Levine
Benjamin Huber
Howard Andrews
Nancy Kerner
Dani Cohen
Scott Carlson
Sophie A. Bell
Andrés Rivera
Marc L. Gordon
Sabrina Simoes
Davangere P. Devanand
Adam M. Brickman
Lon S. Schneider
Philip D. Harvey
Terry E. Goldberg
Affiliated Authors:
Hyun Kim
Seonjoo Lee
Howard Andrews
Nancy Kerner
Andrés Rivera
Sabrina Simoes
Davangere P. Devanand
Adam M. Brickman
Terry E. Goldberg
Author Keywords:
alzheimer's disease
clinical trial methodology
practice effects
psychometrics
Publication Type:
Article
Unique ID:
10.1002/alz.13757
PMID:
Publication Date:
Data Source:
OpenAlex

Record Created: